Clinical Trials · NCT02128334
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Europe B.V.
- Enrollment
- 645
- Start date
- Sep 2013
- Locations
- 52 sites, Russia
- Primary endpoint
- Percentage change in total serum PSA